Mobile stroke units have been shown to accelerate patient evaluation and treatment. Now, for the first time, this speedier management has been shown to translate to clinical benefit for patients.
A study on Cleveland Clinic’s mobile stroke unit reveals one characteristic that seems to particularly drive early IV thrombolysis delivery.
Practice may not make perfect in healthcare, but it can sure make for greater efficiency and effectiveness. This study of our mobile stroke unit’s evolution over three years is a case in point.
A Cleveland Clinic study presented at the 2018 International Stroke Conference suggests these units may help bypass interhospital transfers for patients requiring thrombectomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A slew of randomized trials have confirmed the superiority of endovascular therapy over IV t-PA alone for acute ischemic stroke. Here’s how endovascular therapies can be best deployed to yield the greatest patient benefits.
Initial experience with one of the nation’s first mobile stroke treatment units shows significant reductions in time to imaging and tPA use for ischemic stroke patients.